Remove 2006 Remove Access Remove Treatment
article thumbnail

Which States Are Voting on Psychedelics?

Veriheal

Using psilocybin in small doses, or microdosing, has been shown to aid in the treatment of various mental health issues, including anxiety, depression, PTSD, and obsessive-compulsive disorder. In 2006, the first research paper by Johns Hopkins was published on the positive long-term impact of using psilocybin in a therapeutic study.

article thumbnail

Australia – Policy Analysis: Medicinal cannabis and driving: the intersection of health and road safety policy – “there is little evidence to justify the differential treatment of medicinal cannabis patients, compared with those taking other prescription medications”

Cannabis Law Report

We conclude that in medical-only access models there is little evidence to justify the differential treatment of medicinal cannabis patients, compared with those taking other prescription medications with potentially impairing effects. Faculty of Science, School of Psychology, The University of Sydney, Sydney, NSW 2006, Australia.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Article: UC Berkeley Center for the Science of Psychedelics – Psychedelics and the Law

Cannabis Law Report

As more and more scientific research supports the therapeutic and medicinal potential of psychedelics, states and cities have begun to make these substances more accessible. In 2018, the FDA granted COMPASS Pathways BTD to develop psilocybin therapy for treatment-resistant depression. Where Laws Are Changing.

Law 74
article thumbnail

What seniors need to know before getting a medical marijuana card

The Cannigma

The percentage of Americans over 65 who had reported using cannabis in the past year had increased tenfold between 2006 to 2018, from 0.4% With a medical marijuana card you can also receive preferential treatment at some combined medical/adult use dispensaries. Access to healthcare professionals.

article thumbnail

Policy Analysis Paper: Medicinal cannabis and driving: the intersection of health and road safety policy

Cannabis Law Report

Recent shifting attitudes towards the medical use of cannabis has seen legal access pathways established in many jurisdictions in North America, Europe and Australasia. Others who need to drive are excluded from accessing a needed medication and associated therapeutic benefit. Background. Conclusion. S0955395921002127-main.

Policy 51
article thumbnail

THC or CBD: Which Is for You?

Kind Meds (Cannabis Education Blog)

The greatest benefit of using THC and CBD together in a full-spectrum cannabis product is your ability to access the entourage effect. When you smoke, inhale, or otherwise ingest full-spectrum cannabis, you gain access to a number of cannabis compounds in addition to cannabinoids like THC and CBD. 1] Pacher, P., 6] Ferber, S.

THC 72
article thumbnail

MAPS Is 36 Years Old – Doblin Provides Precis Timeline of the Organization

Cannabis Law Report

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. For over three decades, we’ve been working to achieve mass mental health throughout the United States, Canada, and Europe.